AnnJi Pharmaceutical Statistics

Total Valuation

TPEX:7754 has a market cap or net worth of TWD 2.29 billion. The enterprise value is 1.64 billion.

Market Cap	2.29B
Enterprise Value	1.64B

Important Dates

The next estimated earnings date is Monday, September 22, 2025.

Earnings Date	Sep 22, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:7754 has 93.88 million shares outstanding. The number of shares has increased by 20.01% in one year.

Current Share Class	93.88M
Shares Outstanding	93.88M
Shares Change (YoY)	+20.01%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	1.05%
Owned by Institutions (%)	n/a
Float	58.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.70
PB Ratio	3.45
P/TBV Ratio	4.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.62
EV / Sales	16.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.35

Financial Position

The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.08.

Current Ratio	2.56
Quick Ratio	2.43
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.28
Interest Coverage	-202.10

Financial Efficiency

Return on equity (ROE) is -44.61% and return on invested capital (ROIC) is -26.42%.

Return on Equity (ROE)	-44.61%
Return on Assets (ROA)	-20.37%
Return on Invested Capital (ROIC)	-26.42%
Return on Capital Employed (ROCE)	-50.62%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	23.36
200-Day Moving Average	29.49
Relative Strength Index (RSI)	45.80
Average Volume (20 Days)	247,213

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:7754 had revenue of TWD 96.45 million and -353.99 million in losses. Loss per share was -3.81.

Revenue	96.45M
Gross Profit	8.89M
Operating Income	-360.14M
Pretax Income	-353.99M
Net Income	-353.99M
EBITDA	-322.53M
EBIT	-360.14M
Loss Per Share	-3.81

Full Income Statement

Balance Sheet

The company has 706.01 million in cash and 55.34 million in debt, giving a net cash position of 650.67 million or 6.93 per share.

Cash & Cash Equivalents	706.01M
Total Debt	55.34M
Net Cash	650.67M
Net Cash Per Share	6.93
Equity (Book Value)	662.10M
Book Value Per Share	7.07
Working Capital	453.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -186.01 million and capital expenditures -9.95 million, giving a free cash flow of -195.97 million.

Operating Cash Flow	-186.01M
Capital Expenditures	-9.95M
Free Cash Flow	-195.97M
FCF Per Share	-2.09

Full Cash Flow Statement

Margins

Gross Margin	9.22%
Operating Margin	-373.40%
Pretax Margin	-367.02%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:7754 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.01%
Shareholder Yield	n/a
Earnings Yield	-15.48%
FCF Yield	-8.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:7754 has an Altman Z-Score of 3.64 and a Piotroski F-Score of 1.

Altman Z-Score	3.64
Piotroski F-Score	1